Author:
Koufakis Theocharis,Karras Spyridon N.,Kotsa Kalliopi
Publisher
Springer International Publishing
Reference39 articles.
1. Alfa RW, Park S, Skelly KR et al (2015) Suppression of insulin production and secretion by a decretin hormone. Cell Metab 21:323–334
2. Baldissera FG, Holst JJ, Knuhtsen S et al (1988) Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs. Regul Pept 21:151–166
3. Batterham RL, Cummings DE (2016) Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care 39:893–901
4. Bose M, Teixeira J, Olivan B et al (2010) Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2:47–55
5. Chaudhry S, Bernardes M, Harris PE et al (2016) Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Minerva Endocrinol 41:43–56